Portfolio company
Glyphic Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a single-molecule protein sequencing platform for researchers to identify amino acids and post-translational modifications in the human proteome.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Glyphic
This biotechnology company develops a protein sequencing platform for researchers to accelerate drug discovery and proteomic analysis.
Glyphic Biotechnologies
This company develops a single-molecule protein sequencing platform for researchers and institutions focused on biological research and drug discovery.
Portal Biotech
The company develops nanopore-based instruments for single-molecule protein sequencing to serve researchers in drug discovery, diagnostics and biosecurity sectors.
Constellate Proteomics
This company develops single-molecule protein analysis platforms for biopharmaceutical drug developers to monitor antibody quality and rank cell lines during production.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
Zephyrus Biosciences
This company develops single-cell protein analysis instruments and research tools for academic, biopharmaceutical and clinical scientists conducting disease research.
Open Protein
This company provides a no-code machine learning platform for protein engineering and sequence generation to researchers in biotechnology, pharmaceuticals and academia.
